CA
CA · CA · CA-DIN-02532093
SKYRIZI
ATC L04AC18
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerABBVIE CORPORATION
CountryCA (CA)
ATC codeL04AC18
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02532093",
"form": "SOLUTION",
"class": "Human",
"routes": [
"SUBCUTANEOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "L04AC18",
"schedule": [
"Prescription",
"Schedule D"
],
"drug_code": "102116",
"strengths": [
"360 MG"
],
"ahfs_class": null,
"substances": [
"RISANKIZUMAB"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code L04AC18.
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
- ISSkyriziAbbVie Deutschland GmbH & Co. KG
Access this data programmatically
Query SKYRIZI and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.